Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure

European Journal of Anaesthesiology

Volumn 22, Issue 1, 2005, Pages 4-10

  Robertson, Eric N ^a   Driessen, J J ^a   Booij, L H D J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Kidney failure, chronic; Neuromuscular non depolarizing agents, rocuronium; Pharmacokinetics, rocuronium, metabolites

Indexed keywords

ALUMINUM HYDROXIDE; AMITRIPTYLINE; AMLODIPINE; ATENOLOL; CALCIUM; CAPTOPRIL; CYCLOSPORIN; DRUG METABOLITE; ENALAPRIL; FERROUS SULFATE; FUROSEMIDE; GAVISCON; INSULIN; IPRATROPIUM BROMIDE; LISINOPRIL; METOPROLOL; MINOXIDIL; MULTIVITAMIN; NIFEDIPINE; PREDNISOLONE; PRIMIDONE; PROPOFOL; RECOMBINANT ERYTHROPOIETIN; ROCURONIUM; SALBUTAMOL; SIMVASTATIN; SOTALOL; THEOPHYLLINE; TOLBUTAMIDE; VALPROIC ACID; ANDROSTANE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; KIDNEY FAILURE; MALE; MYOGRAPHY; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; ULNAR NERVE; ADOLESCENT; BIOLOGICAL MODEL; BIOTRANSFORMATION; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTROSTIMULATION; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; NERVE BLOCK; PATIENT MONITORING;

ADOLESCENT; ADULT; AGED; ANDROSTANOLS; BIOTRANSFORMATION; ELECTRIC STIMULATION; FEMALE; HUMANS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MONITORING, INTRAOPERATIVE; NERVE BLOCK; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 20644439564     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021505000025     Document Type: Article

References (16)

1. Mirakhur RK, Cooper R, McCarthy G, Elliot P. Comparison of the intubating conditions and some neuromuscular effects following administration of Org 9426 and succinylcholine. Anesth Analg 1992; 74: S210.
2. Mirakhur RK. Safety aspects on non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide. Eur J Anaesth 1994; 11 (Suppl 9): 133-140.
3. Wierda JMKH, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38: 430-435.
4. Wierda JMKH, Proost JH, Schiere S, Hommes FDM. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans. Eur J Anaesth 1994; 11: 66-74.
5. Khuenl-Brady KS, Pomaroli A, Pühringer F, Mitterschiffthaler G, Koller J. The use of rocuronium in patients with chronic renal failure. Anaesthesia 1993; 48: 873-875.
6. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JMKH, Brady M, Fitzpatrick KTJ. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71: 222-226.
7. Szenohradszky J, Fisher DM, Segredo V, et al. Pharmacokinetics of rocuronium bromide in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992; 77: 899-904.
8. Cooper AR, Wierda JMKH, Mirakhur RK, Maddineni VR. Pharmacodynamics and pharmacokinetics of rocuronium bromide in patients with and without renal failure. Eur J Anaesth 1994; 11 (Suppl 9): 82-84.
9. Kleef UW, Proost JH, Roggeveld J, Wierda JMKH. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. J Chromatogr 1993; 621; 65-76.
10. Press WH, Flannery BP, Teukolsky SA, Vetterling WT (eds). Numerical Recipes. Cambridge: Cambridge University Press, 1986.
11. Wagner JG. Fundamentals of Clinical Pharmacokinetics. Hamilton: Drug Intelligence Publications, 1975.
12. Driessen JJ, Robertson EN, Booij LHDJ, Vree TB. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone. Br J Anaesth 1998; 80: 386-388.
13. McCoy EP, Mirakhur RK, Maddineni VR, Wierda JMKH, Proost JH. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia. Br J Anaesth 1996; 76: 29-33.
14. Van den Broek L, Wierda JMKH, Smeulers NJ, Van Santen GJ, Leclerc MGL, Hennis PJ. Clinical pharmacology of rocuronium: study of the time course of action, dose requirement, reversibility and pharmacokinetics. J Clin Anesth 1994; 6: 288-296.
15. Kheunl-Brady K, Castagnoli KP, Canfell PC, Caldwell JE, Agoston S, Miller RD. The neuromuscular blocking effects and pharmacokinetics of Org 9426 and Org 9616 in the cat. Anesthesiology 1990; 72: 669-674.
16. -1 in children with and without endstage renal failure. Paediatr Anaesth 2002; 12: 507-510.